Theoretical Investigation of Inclusion Complexes of 3-Hydroxyflavone and Quercetin as Guests with Native and Modified β-Cyclodextrins as Hosts

References

• S. P. Fernandez, C. Wasowski, L. M. Loscalzo, R. E. Granger, G. A. R. Johnston, A. C. Paladini, and M. Marder, “Central Nervous System Depressant Action of Flavonoid Glycosides,” European Journal of Pharmacology 539, no. 3 (2006): 168–76.
   PubMed Web of Science ®Google Scholar
• K. E. Heim, A. R. Tagliaferro, and D. J. Bobilya, “Flavonoid Antioxidants: Chemistry, Metabolism and Structure-Activity Relationships,” The Journal of Nutritional Biochemistry 13, no. 10 (2002): 572–84.
   PubMed Web of Science ®Google Scholar
• P. C. H. Hollman and M. B. Katan, “Dietary Flavonoids: Intake, Health Effects and Bioavailability,” Food and Chemical Toxicology 37, no. 9–10 (1999): 937–42.
   PubMed Web of Science ®Google Scholar
• T. P. T. Cushnie and A. J. Lamb, “Antimicrobial Activity of Flavonoids,” International Journal of Antimicrobial Agents 26, no. 5 (2005): 343–56.
   PubMed Web of Science ®Google Scholar
• J. Peterson and M. S. J. Dwyer, “Flavonoids: Dietary Occurrences and Biochemical Activity,” Nutrition Research 18, no. 12 (1998): 1995–2018.
   Web of Science ®Google Scholar
• H. Tsuchiya, “Structure-Dependent Membrane Interaction of Flavonoids Associated with Their Bioactivity,” Food Chemistry. 120, no. 4 (2010): 1089–96.
   Web of Science ®Google Scholar
• N. C. Cook and S. Samman, “Flavonoids-Chemistry, Metabolism, Cardioprotective Effects, and Dietary Sources,” The Journal of Nutritional Biochemistry 7, no. 2 (1996): 66–76.
   Web of Science ®Google Scholar
• C. A. Rice-Evans, N. J. Miller, P. G. Bolwell, P. M. Bramley, and J. B. Pridham, “The Relative Antioxidant Activities of Plant-Derived Polyphenolic Flavonoids,” Free Radical Research 22, no. 4 (1995): 375–83.
   PubMed Web of Science ®Google Scholar
• A. K. Pandey, “Anti-Staphylococcal Activity of a Pan-Tropical Aggressive and Obnoxious Weed Parthenium Histerophorus: An In Vitro Study,” National Academy Science Letters 30 (2007): 383–6.
   Web of Science ®Google Scholar
• S. Kumar and A. K. Pandey, “Phenolic Content,” Vegetos- An International Journal of Plant Research 26, no. 1 (2013): 301–7.
   Google Scholar
• G. Agati, E. Azzarello, S. Pollastri, and M. Tattini, “Flavonoids as Antioxidants in Plants: Location and Functional Significance,” Plant Science: An International Journal of Experimental Plant Biology 196 (2012): 67–76.
   PubMed Web of Science ®Google Scholar
• F. Du, F. Zhang, and F. Chen, Afri, “Advances in Microbial Heterologous Production of Flavonoids,” Journal of Microbiology Research 5 (2011): 2566–74.
   Google Scholar
• M. N. Roy, S. Saha, and M. Nath. Roy, “Probing Inclusion Complex Formation of Amantadine Hydrochloride with 18-Crown-6 in Methanol by Physicochemical Approach,” ZeitschriftfürPhysikalischeChemie 425 (2016): 252–8.
   Google Scholar
• J. Szejtli, “Introduction and General Overview of Cyclodextrin Chemistry,” Chemical Reviews 98, no. 5 (1998): 1743–53.
   PubMed Web of Science ®Google Scholar
• N. L. Pacioni and A. V. Veglia, “Determination of Carbaryl and Carbofuran in Fruits and Tap Water by β-Cyclodextrin Enhanced Fluorimetric Method,” Analytica Chimica Acta 488, no. 2 (2003): 193–202.
   Web of Science ®Google Scholar
• X. Zhu, J. Sun, and J. Wu, “Study on the Inclusion Interactions of Beta-Cyclodextrin and Its Derivative with Dyes by Spectrofluorimetry and its Analytical Application,” Talanta 72, no. 1 (2007): 237–42.
   PubMed Web of Science ®Google Scholar
• C. Yanez, R. Salagar, and L. J. Nunez, “Spectrophotometric and Electrochemical Study of the Inclusion Complex between β-Cyclodextrin and Furnidipine,” Journal of Pharmaceutical and Biomedical Analysis 35 (2004): 51–60.
   PubMed Web of Science ®Google Scholar
• S. Rawat and K. Jain, “Solubility Enhancement of Celecoxib Using Beta-Cyclodextrin Inclusion Complexes,” European Journal of Pharmaceutics and Biopharmaceutics: Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik e.V 57, no. 2 (2004): 263–7.
   PubMed Web of Science ®Google Scholar
• J. J. Berzas, A. Alañón, and J. A. Lázaro, “Cyclodextrin Enhanced Spectrofluorimetric Determination of Fluoxetine in Pharmaceuticals and Biological Fluids,” Talanta 58, no. 2 (2002): 301–9.
   PubMed Web of Science ®Google Scholar
• S. O. Fakayode, I. M. Swamidoss, M. A. Busch, and K. W. Busch, “Determination of the Enantiomeric Composition of Some Molecules of Pharmaceutical Interest by Chemometric Analysis of the UV Spectra of Guest-Host Complexes Formed with Modified Cyclodextrins,” Talanta 65, no. 4 (2005): 838–45.
   PubMed Web of Science ®Google Scholar
• O. Csernak, A. Buvari-Barcza, and L. Barcza, “Cyclodextrin Assisted Nanophase Determination of Alkaloid Salts,” Talanta 69, no. 2 (2006): 425–9.
   PubMed Web of Science ®Google Scholar
• G. Zhang, S. Shuang, C. Dong, and J. Pan, “Study on the Interaction of Methylene Blue with Cyclodextrin Derivatives by Absorption and Fluorescence Spectroscopy,” Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 59, no. 13 (2003): 2935–41.
   PubMed Web of Science ®Google Scholar
• A. R. Katageri and M. A. Sheikh, “Cyclodextrin a Gift to Pharmaceutical World Review,” International Research Journal of Pharmacy 3 (2012): 52–6.
   Google Scholar
• B. D. Shewale, N. P. Sapkal, N. A. Raut, N. J. Gaikwad, and R. A. Fursule, “Effect of Hydroxylpropyl-Beta-Cyclodextrin on Solubility of Carvedilol,” Indian Journal of Pharmaceutical Sciences 70, no. 2 (2008): 255–7.
   PubMed Web of Science ®Google Scholar
• T. Loftsson, P. Jansook, and E. Stefánsson, “Topical Drug Delivery to the Eye: Dorzolamide,” Acta Ophthalmologica 90, no. 7 (2012): 603–8.
   PubMed Web of Science ®Google Scholar
• V. M. Rao, M. Nerurkar, S. Pinnamaneni, F. Rinaldi, and K. Raghavan, “Co-Solubilization of Poorly Soluble Drugs by Micellization and Complexation,” International Journal of Pharmaceutics 319, no. 1–2 (2006): 98–106.
   PubMed Web of Science ®Google Scholar
• E. C. Yang, X. J. Zhao, F. Hua, and J. K. Hao, “Semi-Empirical PM3 Study upon the Complexation of β-Cyclodextrin with 4,4′-Benzidine and o-Tolidine,” Journal of Molecular Structure 712, no. 1–3 (2004): 75–9.
   Web of Science ®Google Scholar
• R. Djemil and D. Khatmi, “Theoretical Study of Inclusion Complexes of Dopamine with β-Cyclodextrin Based on PM6, ONIOM, and Natural Bonding Orbital Analysis,” Canadian Journal of Chemistry 89, no. 12 (2011): 1519–24.
   Web of Science ®Google Scholar
• F. Madi, L. Largate, L. Nouar, and D. Khatmi, “Theoretical Study of the Inclusion Processes of Ethyl p-Hydroxybenzoate with β-Cyclodextrin: PM3MM and ONIOM2 Calculations,” Journal of the Taiwan Institute of Chemical Engineers 43 (2012): 868–72.
   Web of Science ®Google Scholar
• A. Praveena, S. Prabu, and R. Rajamohan, “Encapsulation of Quercetin in β-Cyclodextrin and (2-Hydroxypropyl)-β-Cyclodextrin Cavity: In-Vitro Cytotoxic Evaluation,” Journal of Macromolecular Science, Part A 54, no. 12 (2017): 894–901.
   Web of Science ®Google Scholar
• A. Praveena, M. Swaminathan, S. Prabu, and R. Rajamohan, “Host-Guest Complexation between 3-Hydroxyflavone and β-Cyclodextrin: Preparation, Characterization and Cytotoxicity Studies,” Indian Journal of Chemistry -Section A no. 55A (2016): 435–40.
   Google Scholar